Relationship of senile ptosis to age

Annals of Ophthalmology
|October 1, 1984
PubMed

Insights

Senile ptosis, an age-related eyelid condition, progressively worsens with age from childhood in both sexes. This suggests ptosis is a lifelong cumulative process, not exclusive to the elderly.

Area of Science:

  • Ophthalmology
  • Gerontology

Background:

  • Senile ptosis is commonly perceived as a condition affecting only older individuals.
  • The developmental trajectory of senile ptosis across the lifespan is not well-established.

Purpose of the Study:

  • To investigate the relationship between patient age and the degree of senile ptosis.
  • To determine if senile ptosis onset occurs earlier than typically assumed.

Main Methods:

  • A cross-sectional study involving 1,073 randomly selected patients.
  • Quantitative assessment of senile ptosis severity.
  • Statistical analysis correlating age with ptosis measurements.

Main Results:

  • A statistically significant, progressive increase in senile ptosis was observed with advancing age.
  • This age-related increase in ptosis was evident in both male and female participants.
  • The onset of ptosis progression was noted to begin in childhood.

Conclusions:

  • Senile ptosis is not a disorder exclusive to advanced age.
  • Ptosis represents a cumulative process that begins in early life.
  • The noticeable manifestation of senile ptosis in later years is a result of lifelong accumulation.

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Prosopagnosia01:24

Prosopagnosia

Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...